Aurora Cancer Care-Racine
Racine, Wisconsin, United States
Cancer treatment center in Mount Pleasant, Wisconsin
8400 Washington Ave Ste 203, Racine, WI 53406
About Aurora Cancer Care-Racine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
82
SWOG Cancer Research Network
28
Alliance for Clinical Trials in Oncology
20
ECOG-ACRIN Cancer Research Group
14
NRG Oncology
12
Wake Forest University Health Sciences
2
American Society of Clinical Oncology
1
GOG Foundation
1
Gynecologic Oncology Group
1
NSABP Foundation Inc
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Clinical Trials at Aurora Cancer Care-Racine
During the past decade, Aurora Cancer Care-Racine conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 57 clinical trials were completed, i.e. on
average, 52.8% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 41 clinical trials were completed. i.e. 157.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer
2008-07-30
2019-10-15
Completed
64
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Aurora Cancer Care-Racine" #1 sponsor was "National Cancer Institute (NCI)" with 82 trials, followed by "SWOG Cancer Research Network" with 28 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "NRG Oncology"
with 14 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Cancer Care-Racine"
#1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 30 trials.
Clinical Trials Conditions at Aurora Cancer Care-Racine
According to Clinical.Site data, the most researched conditions in "Aurora Cancer Care-Racine" are
"Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Aurora Cancer Care-Racine" in a lesser frequency.
Clinical Trials Intervention Types at Aurora Cancer Care-Racine
Most popular intervention types in "Aurora Cancer Care-Racine" are "Drug" (132 trials), "Other" (111 trials), "Biological" (68 trials), "Procedure" (46 trials) and "Radiation" (26 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (53 trials), "Laboratory Biomarker Analysis" (52 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (24 trials) and "Biospecimen Collection" (20 trials). Other intervention names were less common.
Clinical Trials Genders at Aurora Cancer Care-Racine
The vast majority of trials in "Aurora Cancer Care-Racine" are
133 trials for "All" genders, 25 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Aurora Cancer Care-Racine
Currently, there are NaN active trials in "Aurora Cancer Care-Racine".
undefined are not yet recruiting,
46 are recruiting,
86 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Aurora Cancer Care-Racine,
6 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Aurora Cancer Care-Racine, 3 "Phase 1"
clinical trials were conducted, 76 "Phase 2" clinical
trials and 96 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".